| 今开：20.62 | 昨收：20.56 |
| 最高：20.88 | 最低：20.315 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.104492555E9 |
Prothena(PRTA)02-09 22:55
$Prothena(PRTA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001510 Act: 34 Size: 8 KB 网页链接查看全文
Prothena(PRTA)03-01 10:05
$Prothena(PRTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000834 Size: 5 KB 网页链接查看全文
Prothena(PRTA)03-01 10:05
$Prothena(PRTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000835 Size: 5 KB 网页链接查看全文
Prothena(PRTA)03-01 10:15
$Prothena(PRTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000838 Size: 5 KB 网页链接查看全文
Prothena(PRTA)03-01 10:15
$Prothena(PRTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000841 Size: 5 KB 网页链接查看全文
Prothena(PRTA)02-24 06:45
$Prothena(PRTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000791 Size: 5 KB 网页链接查看全文
Prothena(PRTA)02-24 06:45
$Prothena(PRTA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000905148-24-000790 Size: 12 KB 网页链接查看全文
Prothena(PRTA)02-15 01:25
$Prothena(PRTA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-035658 Act: 34 Size: 47 KB 网页链接查看全文
Prothena(PRTA)02-14 23:05
$Prothena(PRTA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000080255-24-000703 Act: 34 Size: 6 KB 网页链接查看全文
Prothena(PRTA)03-30 05:05
$Prothena(PRTA)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-24-016622 Act: 34 Size: 9 MB 网页链接查看全文
智通财经APP获悉，北京时间7月12日，诺和诺德(NVO.US)与Prothena(PRTA.US)宣布，双方已达成最终收购协议，诺和诺德将收购Prothena的临床阶段抗体PRX004和转甲状腺素蛋白淀粉样变性(ATTR)项目。 根据收购协议条款，诺和诺德收购Prothena... 网页链接
凤凰网港股|Prothena公司（PRTA）宣布，百时美施贵宝（BMY）行使其在全球神经科学研究和开发合作中的选择权，进入PRX005的美国独家许可，并将向Prothena支付8000万美金。 PRX005被设计成一种抗tau抗体，专门针对微管结合区的一个区域，用于... 网页链接
智通财经APP获悉，在美国食品药品监督管理局(FDA)昨日批准百健(BIIB.US)的阿尔茨海默症药物Aduhelm后，投行Oppenheimer将Prothena (PRTA.US)的目标价上调至54美元。 该行称，Aduhelm的批准为“其他阿尔茨海默症药物候选者树立了重要的先... 网页链接
$Prothena(PRTA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-24-016626 Act: 34 Size: 1 MB 网页链接
$Prothena(PRTA)$ ARS Annual Report to Security Holders Accession Number: 0001140361-24-016628 Act: 34 Size: 2 MB 网页链接
$Prothena(PRTA)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-24-016622 Act: 34 Size: 9 MB 网页链接
$Prothena(PRTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000889 Size: 5 KB 网页链接
$Prothena(PRTA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000905148-24-000888 Size: 12 KB 网页链接
$Prothena(PRTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000836 Size: 5 KB 网页链接
$Prothena(PRTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000838 Size: 5 KB 网页链接
$Prothena(PRTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000839 Size: 5 KB 网页链接
$Prothena(PRTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000841 Size: 5 KB 网页链接
$Prothena(PRTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000905148-24-000840 Size: 5 KB 网页链接